{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:41:18Z","timestamp":1792291278499,"version":"4.4.0"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Gallbladder carcinoma (GBC) represents one of the most aggressive malignancies of the hepatobiliary system, evolving along a continuum from chronic inflammation to preneoplastic lesions and invasive cancer. This progression is frequently associated with gallstones and chronic cholecystitis and shares common pathogenic mechanisms with systemic inflammatory and metabolic disorders. Despite its relatively low incidence, GBC is characterized by poor prognosis, largely due to late-stage diagnosis and limited understanding of its molecular underpinnings. Methods: We conducted an observational study including 60 adult patients with radiologically suspected gallbladder cancer (GBC). Patients with disseminated disease, ongoing oncologic treatment, or synchronous malignancies were excluded. Fasting venous blood samples were collected to evaluate tumor markers and biochemical parameters, including carcinoembryonic antigen (CEA) and carbohydrate antigen CA 19-9. Surgical specimens were analyzed histopathologically and staged according to the European Society for Medical Oncology TNM classification system. Statistical analysis was performed using SPSS software (version 26.0), with appropriate parametric or non-parametric tests applied based on data distribution, and a p-value &lt; 0.05 considered statistically significant. Results: Based on histological findings, patients were stratified into benign gallbladder disease (GBD) and GBC groups. CA 19-9 demonstrated higher mean serum levels with lower variability compared to CEA, suggesting superior sensitivity and diagnostic stability for gallbladder adenocarcinoma. In contrast, CEA levels exhibited greater fluctuation, limiting its reliability as a standalone biomarker. Importantly, the combined use of CA 19-9 and CEA improved diagnostic accuracy, supporting a multimarker approach for better clinical stratification. Our findings highlight the diagnostic value of CA 19-9 as a robust biomarker in GBC and support the integration of combined biomarker panels. Beyond tumor markers, the study identified a strong interplay between systemic inflammation and metabolic comorbidities, with obesity and hypertension significantly associated with chronic gallbladder pathology, and diabetes mellitus contributing to increased risk of acute inflammatory episodes. Elevated inflammatory markers, leukocytosis, and cholestatic enzyme alterations further supported the presence of a systemic inflammatory milieu. Multivariate analysis revealed that C-reactive protein (CRP), as a marker of systemic inflammation, was significantly influenced by a combination of clinical and biochemical variables, including age, hemoglobin, hypertension, amylase, CA 19-9, and CEA, explaining over 50% of its variability and up to 85% in advanced fibrotic changes. Additionally, platelet counts were significantly reduced in adenocarcinoma and correlated specifically with CA 19-9 levels, suggesting a potential link between tumor burden, inflammation, and platelet dynamics. Conclusions: Therefore, the observed associations between chronic inflammation, metabolic dysregulation, and tumor marker expression suggest a potential link between gallbladder carcinogenesis and systemic cardiometabolic pathways, opening new perspectives for early detection and targeted therapeutic strategies.<\/jats:p>","DOI":"10.3390\/diagnostics16101480","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:46:55Z","timestamp":1778676415000},"page":"1480","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and Molecular Signatures of Gallbladder Lesions: Insights into Metabolic and Inflammatory Pathways"],"prefix":"10.3390","volume":"16","author":[{"given":"Andrei","family":"Bojan","sequence":"first","affiliation":[{"name":"Department of Surgical Specialties I, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Vladeanu","sequence":"additional","affiliation":[{"name":"Department of Morpho Functional Sciences, Physiopathology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin","family":"Pricop","sequence":"additional","affiliation":[{"name":"Department of Surgical Specialties I, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Bararu-Bojan","sequence":"additional","affiliation":[{"name":"Department of Morpho Functional Sciences, Physiopathology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9989-1653","authenticated-orcid":false,"given":"Cezar Ilie","family":"Foia","sequence":"additional","affiliation":[{"name":"Department of Surgical Specialties I, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Eliza","family":"Giusca","sequence":"additional","affiliation":[{"name":"Department of Morpho Functional Sciences, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Iliescu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7050-8430","authenticated-orcid":false,"given":"Oana Viola","family":"Badulescu","sequence":"additional","affiliation":[{"name":"Department of Morpho Functional Sciences, Physiopathology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Codruta Olimpiada Iliescu","family":"Halitchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-5234","authenticated-orcid":false,"given":"Maria Alexandra","family":"Martu","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Faculty of Dental Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Bazyani","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Heart Institute, 700503 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-2175","authenticated-orcid":false,"given":"Manuela","family":"Ciocoiu","sequence":"additional","affiliation":[{"name":"Department of Morpho Functional Sciences, Physiopathology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7558-0711","authenticated-orcid":false,"given":"Liliana Georgeta","family":"Foia","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Dental Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/CEJ.0000000000000588","article-title":"Gallbladder disease and pancreatic cancer risk: A multicentric case-control European study","volume":"30","author":"Rosato","year":"2021","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_2","first-page":"EC12","article-title":"Immunohistochemical study of MUC1 and MUC5AC expression in gall bladder lesions","volume":"11","author":"Bhoge","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdu006","article-title":"A genetic model for gallbladder carcinogenesis and its dissemination","volume":"25","author":"Barreto","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bojan, A., Pricop, C., Ciocoiu, M., Vladeanu, M.C., Bararu Bojan, I., Badulescu, O.V., Badescu, M.C., Plesoianu, C.E., Halitchi, D.I., and Foia, L.G. (2024). Environmental and Metabolic Risk Factors Linked to Gallbladder Dysplasia. Metabolites, 14.","DOI":"10.3390\/metabo14050273"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/SLA.0000000000000495","article-title":"Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer","volume":"260","author":"Jain","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3892\/etm.2022.11541","article-title":"Understanding the mechanisms of gallbladder lesions: A systematic review","volume":"24","author":"Bojan","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.humpath.2021.05.001","article-title":"Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer","volume":"114","author":"Mochidome","year":"2021","journal-title":"Hum. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"He, C.Z., Zhang, K.H., Li, Q., Liu, X.H., Hong, Y., and Lv, N.H. (2013). Combined use of AFP, CEA, CA125 and CA 19-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-87"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.3748\/wjg.v20.i14.4085","article-title":"Combined detection tumour markers for diagnosis and prognosis of gallbladder cancer","volume":"20","author":"Wang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_11","first-page":"1297","article-title":"Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population","volume":"60","author":"Zhang","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e925017","DOI":"10.12659\/MSM.925017","article-title":"The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer","volume":"26","author":"Ma","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1111\/ans.14893","article-title":"Clinical value of preoperative CA19-9 levels in evaluating resectability of gallbladder carcinoma","volume":"89","author":"Liu","year":"2019","journal-title":"ANZ J. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","article-title":"Gallbladder cancer: Diagnosis, surgical management, and adjuvant therapies","volume":"99","author":"Hickman","year":"2019","journal-title":"Surg. Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.amjsurg.2008.12.031","article-title":"CA19-9 serum levels in obstructive jaundice: Clinical value in benign and malignant conditions","volume":"198","author":"Marrelli","year":"2009","journal-title":"Am. J. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"Rawla","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"zraf056","DOI":"10.1093\/bjsopen\/zraf056","article-title":"Assessment of nodal staging and risk factors for nodal involvement in gallbladder cancer","volume":"9","author":"Balakrishnan","year":"2025","journal-title":"BJS Open"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3760\/cma.j.issn.0366-6999.20131734","article-title":"Preoperative prediction of survival in resectable gallbladder cancer by a combined utilization of CA 19-9 and carcinoembryonic antigen","volume":"127","author":"Yu","year":"2014","journal-title":"Chin. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.hpb.2017.06.011","article-title":"Elevation of CA19\u20139 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma","volume":"19","author":"Wen","year":"2017","journal-title":"HPB"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/jcar.JCar_10_20","article-title":"Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder","volume":"19","author":"Agrawal","year":"2020","journal-title":"J. Carcinog."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sachan, A., Saluja, S.S., Nekarakanti, P.K., Nimisha Mahajan, B., Nag, H.H., and Mishra, P.K. (2020). Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07334-x"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/17246008211068866","article-title":"Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer","volume":"37","author":"Zhou","year":"2022","journal-title":"Int. J. Biol. Markers"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4240\/wjgs.v14.i11.1272","article-title":"Assessment of tumour markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer","volume":"14","author":"Sinha","year":"2022","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_24","first-page":"160","article-title":"Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder","volume":"27","author":"Shukla","year":"2006","journal-title":"Trop. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jso.23476","article-title":"Ability of FDG-PET\/CT in the detection of gallbladder cancer","volume":"109","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1724600818820679","article-title":"Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer","volume":"34","author":"Ramphal","year":"2019","journal-title":"Int. J. Biol. Markers"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amjsurg.2017.02.006","article-title":"Predictors of curative resection and long term survival of gall bladder cancer\u2014A retrospective analysis","volume":"214","author":"Mishra","year":"2017","journal-title":"Am. J. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.2910450505","article-title":"Serum CEA and CA 19-9: Potential future diagnostic or screening tests for gallbladder cancer?","volume":"45","author":"Strom","year":"1990","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1245\/s10434-008-9917-y","article-title":"A new scoring system for gallbladder cancer (aiding treatment algorithm): An analysis of 335 patients","volume":"15","author":"Shukla","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"117882","DOI":"10.1016\/j.cca.2024.117882","article-title":"Electrochemical immunosensing of tumor markers","volume":"557","author":"Palakollu","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/1319-3767.105922","article-title":"p53 and beta-catenin expression in gallbladder tissues and correlation with tumour progression in gallbladder cancer","volume":"19","author":"Ghosh","year":"2013","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_32","first-page":"101","article-title":"Bile duct involvement portends poor prognosis in resected gallbladder carcinoma","volume":"6","author":"Eil","year":"2013","journal-title":"Gastrointest. Cancer Res."},{"key":"ref_33","first-page":"99","article-title":"Gallbladder cancer: Epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","article-title":"Updated epidemiology of gastrointestinal cancers in East Asia","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.17305\/bb.2024.10704","article-title":"Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach","volume":"25","author":"Rawal","year":"2024","journal-title":"Biomol. Biomed."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"0203103","DOI":"10.14319\/ijcto.0203.10","article-title":"Gall stones size, number, biochemical analysis and lipidogram-an association with gall bladder cancer: A study of 200 cases","volume":"2","author":"Narang","year":"2014","journal-title":"Int. J. Cancer Ther. Oncol."},{"key":"ref_37","first-page":"26","article-title":"Metaplastic changes in chronic cholecystitis: Implications for early diagnosis and surgical intervention to prevent the gallbladder metaplasia-dysplasia-carcinoma sequence","volume":"6","author":"Seretis","year":"2014","journal-title":"J. Clin. Med. Res."},{"key":"ref_38","first-page":"201","article-title":"Histological changes in gallbladder due to stone disease","volume":"68","author":"Khanna","year":"2006","journal-title":"Indian J. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14701\/ahbps.23-010","article-title":"Histopathological changes in gall bladder mucosa in relation to the number, and size of gallstones, and analysis of the findings in the context of age distribution of the patients: A perspective","volume":"27","author":"Sharma","year":"2023","journal-title":"Ann. Hepatobiliary Pancreat. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5455\/umj.20180324011035","article-title":"Gallstones in young population","volume":"4","author":"Shafique","year":"2018","journal-title":"J. Ulutas Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1194\/jlr.R800075-JLR200","article-title":"Biliary lipids and cholesterol gallstone disease","volume":"50","author":"Dq","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gong, W., Wen, S., Chen, Y., Wu, F., Yang, M., Sun, P., Guo, X., Li, M., Chen, D., and Zhao, H. (2025). Deciphering ERR family genes as prognostic and immunological biomarkers through pan-cancer analysis with validation in gallbladder cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1525635"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12014-023-09399-9","article-title":"Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry","volume":"20","author":"Baichan","year":"2023","journal-title":"Clin. Proteom."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"23554","DOI":"10.1038\/s41598-021-02923-7","article-title":"Plasma-derived candidate biomarkers for detection of gallbladder carcinoma","volume":"11","author":"Priya","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101365","DOI":"10.1016\/j.jhepr.2025.101365","article-title":"Towards precision medicine strategies using plasma proteomic profiling for suspected gallbladder cancer: A pilot study","volume":"7","author":"Nouairia","year":"2025","journal-title":"JHEP Rep."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1480\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:21:01Z","timestamp":1778678461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diagnostics16101480"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16101480","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}